Skip to main content
Clinical Trials/ChiCTR-OPC-17012665
ChiCTR-OPC-17012665Not yet recruitingPhase 4

术前与术后先天性心脏患儿做心脏彩超时右美托咪定镇静半数有效剂量的比较

自筹1 site in 1 country60 target enrollmentStarted: September 18, 2017Last updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
心率

Study Overview

Brief Summary

1.用序贯法研究右美托咪定滴鼻镇静用于小儿先天性心脏病术前经胸壁超声心动图检查的半数有效量; 2.用序贯法研究右美托咪定滴鼻镇静用于术后小儿经胸壁超声心动图检查的半数有效量; 3.比较右美托咪定滴鼻镇静用于术前和先心术后小儿经胸壁超声心动图检查的半数有效量,以更好的指导临床应用。

Study Design

Study Type
观察性研究
Primary Purpose
队列研究

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 0-48 个月,非紫绀型先心病患者,需经胸壁超声心动图检查的,ASA 评分Ⅰ-Ⅱ级

Exclusion Criteria

  • 1.右美托咪定过敏患儿; 2.近期使用过α2 受体激动剂; 3.肝肾功能障碍; 4.鼻腔分泌物较多,鼻部畸形; 5.早产儿

Arms & Interventions

1

有美托咪定滴鼻 1μg/Kg~4μg/Kg

2

有美托咪定滴鼻 1μg/Kg~4μg/Kg

Outcomes

Primary Outcomes

心率

血氧饱和度

呼吸速率

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
自筹

Study Sites (1)

Loading locations...

Similar Trials